|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.065 AUD | +1.56% |
|
+6.56% | -18.75% |
| Apr. 16 | Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing | MT |
| Mar. 27 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
Amplia Therapeutics Limited filed its Annual on May 30, 2023 for the period ending Mar 31, 2023. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.75% | 8.22M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
AMPLIA THERAPEUTICS LIMITED 
